Healthpeak Properties Inc [DOC] stock is trading at $21.71, up 1.31%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DOC shares have gain 2.16% over the last week, with a monthly amount drifted -6.10%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Healthpeak Properties Inc [NYSE: DOC] stock has seen the most recent analyst activity on October 21, 2024, when Deutsche Bank upgraded its rating to a Buy and also boosted its price target to $28 from $20. Previously, Wedbush upgraded its rating to Outperform on May 03, 2024. On April 26, 2024, upgrade upgraded it’s rating to Outperform and revised its price target to $21 on the stock. BofA Securities upgraded its rating to a Buy and raised its price target to $25 on April 01, 2024.
Healthpeak Properties Inc [DOC] stock has fluctuated between $16.01 and $23.26 over the past year. Currently, Wall Street analysts expect the stock to reach $20.77 within the next 12 months. Healthpeak Properties Inc [NYSE: DOC] shares were valued at $21.71 at the most recent close of the market. An investor can expect a potential drop of -4.33% based on the average DOC price forecast.
Analyzing the DOC fundamentals
Healthpeak Properties Inc [NYSE:DOC] reported sales of 2.56B for the trailing twelve months, which represents a growth of 25.92%. Gross Profit Margin for this corporation currently stands at 0.26% with Operating Profit Margin at 0.15%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.39 points at the first support level, and at 21.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 21.93, and for the 2nd resistance point, it is at 22.14.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 6.06, the price to book ratio is 1.77 and price to earnings (TTM) ratio is 46.43.
Transactions by insiders
Recent insider trading involved Hall Amy M, SVP-Leasing&Physician Strategy, that happened on Dec 08 ’23 when 4001.0 shares were sold.